437.74 USD
↗ 3.50 (0.81%)AT CLOSE (03:59 PM EDT)
Madrigal Pharmaceuticals, Inc. Common Stock
MDGLNASDAQ • USD
437.92
↗ 0.18 (0.04%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
437.92
↗ 0.18 (0.04%)
Market: CLOSED
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently trading at $437.42. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 26, 2026.
Open?$435.66
High?$443.60
Low?$432.12
Prev. Close?$434.24
Volume?275.9K
Avg. Volume?278.8K
VWAP?$438.64
Rel. Volume?0.99x
Bid / Ask
Bid?$413.25 × 40
Ask?$460.06 × 40
Spread?$46.81
Midpoint?$436.66
Valuation & Ratios
Market Cap?10.0B
Shares Out?23.1M
Float?14.9M
Float %?64.6%
P/E Ratio?N/A
P/B Ratio?19.16
EPS?-$14.07
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Employees
915
Market Cap
10.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2007-02-06
Address
1001 CONSHOHOCKEN STATE ROAD
WEST CONSHOHOCKEN, PA
Phone: (267) 824-2827
WEST CONSHOHOCKEN, PA
Phone: (267) 824-2827
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?62
Short Sent.?40
Piotroski F-Score?1/9Weak
Altman Z-Score?6.80Safe
Confidence?58%Low
Short InterestHigh
Short % of Float?14.71%High
Short Interest?2.2M
Days to Cover?7.2
Free Float14.9M
Avg Daily Volume303.1K
Settlement Date2026-10-15
Financial Health
Current Ratio?3.20Strong
Quick Ratio?2.94Strong
Cash Ratio?0.78Adequate
Debt/Equity?0.65Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?19.16HIGH▾
Peers100
S&P8
P/S?7.81HIGH▾
Peers100
S&P14
P/FCF?N/A▾
EV/EBITDA?-31.4CHEAP▾
S&P97
EV/Sales?7.85HIGH▾
Peers100
S&P17
Returns & Efficiency
ROE?-62.1%WEAK▾
S&P3
ROA?-26.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-206285000
Enterprise Value?$10.1B
Fundamentals ratios updated end of day